Sub-Total: $0.00
Specialty
Showing 49–64 of 69 results
-
Emerging Strategies in the Diagnosis and Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD)
Read more -
New Era in the Lipid Lowering Treatment with PCSK9 Inhibitors (Evolocumab and Alirocumab) in Patients with Atherosclerotic Cardiovascular Disease and Familial Hypercholesterolemia
Read more -
Emerging Strategies in the Diagnosis and Treatment of Interstitial Lung Disease (ILD)
Read more -
Emerging Strategies in the Anti–Interleukin-5 Monoclonal Antibody Based Targeted Therapies for Eosinophilic Granulomatosis with Polyangiitis (EGPA)
Read more -
Efficacy and Safety of Fixed-ratio Combination of Insulin Degludec and Liraglutide (IDegLira) and Insulin Glargine and Lixisenatide (IGlarLixi) in Patients with Type 2 Diabetes
Read more -
Emerging Strategies in the Monoclonal Antibodies Targeting Calcitonin Gene-related Peptide (CGRP) or its Receptor in the Preventive Treatment of Migraine
Read more -
Emerging Strategies in the Management of Dyslipidemia in Patients with Atherosclerotic Cardiovascular Disease and Familial Hypercholesterolemia: PCSK9 Inhibitors (Evolocumab and Alirocumab)
Read more -
Changing Landscape of Biological Therapies for Psoriasis: Promising Efficacy of Interleukin-17 (IL-17) and IL-2 Pathway Inhibitors
Read more -
Advances in Biological Therapy of Crohn’s Disease and Ulcerative Colitis
Read more -
Emerging Immunotherapeutic Strategies for Poorly Controlled Asthma
Read more -
Advances in GLP-1 Receptor Agonists, Insulins and SGLT-2 Inhibitors in the Treatment of Diabetes
Read more -
Individualized Treatment Options for Type 2 Diabetes: Comparative Effectiveness of GLP-1 Receptor Agonists on Glycemic Control, Weight Reduction and Cardiovascular Risk
Read more -
Emerging Strategies in the Treatment of Parkinson’s Disease: Management of Non-Motor, Motor and Psychotic Symptoms
Read more -
Emerging Biological Therapies for Atopic Dermatitis in Children and Adults
Read more -
Biological Therapies for PsA, Osteoarthritis, SLE and Spondyloarthritis: Comparative Effectiveness Based on Treatment Profiles and ACR/EULAR Recommendations
Read more -
Emerging Biological Therapies for Psoriasis: Promising Efficacy of Interleukin‐17 (IL‐17) and IL‐23 Pathway Inhibitors
Read more
